Sartorius Stedim Biotech launched a new wave mixed system developed specifically for closed, automated expansion of consistent quality cell products such as ex vivo cellular immunotherapies. The new GMP platform, which combines the single-use Flexsafe bag technology with the company’s expertise in biopharmaceutical automation, was introduced at Phacilitate Leaders World 2019 in Miami.
Read on